US FDA approves expanded use of Miruma drug for liver disease
The U.S. Food and Drug Administration has approved the expanded use of Mirum Pharmaceuticals’ oral drug for the treatment of pruritus caused by liver disease in patients aged five years and older, the company said Wednesday.
POPULAR POSTS
IEA warns ‘electricity era’ will come after fossil fuels peak
October 17, 2024
Easter Island fights global plastic waste vortex
October 17, 2024
Egypt opens more galleries at its antiquities museum
October 17, 2024
LIVE STREAM